Cargando…

Molecular docking analysis of fluoroquinolones and other natural and synthetic compounds with the HCV NS3 helicase

It is of an interest to document the molecular docking analysis of fluoroquinolones and other natural and synthetic compounds with the HCV NS3 helicase. Data shows that three fluoroquinolones interacted with the NS3 helicase in the catalytic region, targeting some of the amino acids known to play a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ul Haq, Ahtesham, Sheikh, Alisalman, Naeem, Sadaf, Abidi, Syed Hani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722412/ https://www.ncbi.nlm.nih.gov/pubmed/36518146 http://dx.doi.org/10.6026/97320630018147

Ejemplares similares

Docking Studies of Pakistani HCV NS3 Helicase: A Possible Antiviral Drug Target
por: Fatima, Kaneez, et al.
Publicado: (2014)

Molecular docking and simulation of Zika virus NS3 helicase
por: Badshah, Syed Lal, et al.
Publicado: (2019)

Simian Virus 40 Large T Antigen as a Model to Test the Efficacy of Flouroquinolones against Viral Helicases
por: Siddiqui, Sammer, et al.
Publicado: (2018)

Molecular screening of phytochemicals from Amelanchier Alnifolia against HCV NS3 protease/helicase using computational docking techniques
por: Khan, Mahim, et al.
Publicado: (2013)

Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease
por: El-Araby, Moustafa E., et al.
Publicado: (2020)

In Silico Identification and Evaluation of Leads for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease Using Complex Based Pharmacophore Mapping and Virtual Screening
por: Wadood, Abdul, et al.
Publicado: (2014)

An in silico approach to analyze HCV genotype-specific binding-site variation and its effect on drug–protein interaction
por: Khalid, Ramsha, et al.
Publicado: (2020)

NS3/4A helicase inhibitory alkaloids from Aptenia cordifolia as HCV target
por: Elgoud Said, Asmaa Abo, et al.
Publicado: (2021)

Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues
por: Ahmed, Khalid, et al.
Publicado: (2022)

Molecular docking study of P4-Benzoxaborolesubstituted ligands as inhibitors of HCV NS3/4A protease
por: Wadood, Abdul, et al.
Publicado: (2013)

pH-Dependent Conformational Changes in the HCV NS3 Protein Modulate Its ATPase and Helicase Activities
por: Ventura, Gustavo Tavares, et al.
Publicado: (2014)

Four Aromatic Sulfates with an Inhibitory Effect against HCV NS3 Helicase from the Crinoid Alloeocomatella polycladia
por: Hermawan, Idam, et al.
Publicado: (2017)

Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking
por: Karpiński, Tomasz M., et al.
Publicado: (2023)

Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients
por: Sadri, Mahrou, et al.
Publicado: (2015)

Natural HCV variants with increased replicative fitness due to NS3 helicase mutations in the C-terminal helix α(18)
por: Stross, Claudia, et al.
Publicado: (2016)

Structure of NS3 helicase from Zika virus
por: Jain, Rinku, et al.
Publicado: (2016)

First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients
por: Hasanshahi, Zahra, et al.
Publicado: (2021)

Dengue Virus NS4b N-Terminus Disordered Region Interacts with NS3 Helicase C-Terminal Subdomain to Enhance Helicase Activity
por: Kundharapu, Satyamurthy, et al.
Publicado: (2022)

RNA Unwinding by NS3 Helicase: A Statistical Approach
por: Arunajadai, Srikesh G.
Publicado: (2009)

Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase
por: Beran, Rudolf K. F., et al.
Publicado: (2008)

Zika virus NS3 is a canonical RNA helicase stimulated by NS5 RNA polymerase
por: Xu, Shan, et al.
Publicado: (2019)

Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity
por: Isken, Olaf, et al.
Publicado: (2022)

Inverse Molecular Docking Study of NS3-Helicase and NS5-RNA Polymerase of Zika Virus as Possible Therapeutic Targets of Ligands Derived from Marcetia taxifolia and Its Implications to Dengue Virus
por: Buendia-Atencio, Cristian, et al.
Publicado: (2021)

Crystal structure of the NS3-like helicase from Alongshan virus
por: Gao, Xiaopan, et al.
Publicado: (2020)

NS3 helicase inhibitory potential of the marine sponge Spongia irregularis
por: Abdelaleem, Enas Reda, et al.
Publicado: (2022)

Insights into the product release mechanism of dengue virus NS3 helicase
por: Adler, Natalia S, et al.
Publicado: (2022)

Molecular Docking Based Screening of Plant Flavonoids as Dengue NS1 Inhibitors
por: Qamar, Muhammad Tahir ul, et al.
Publicado: (2014)

The New High Resolution Crystal Structure of NS2B-NS3 Protease of Zika Virus
por: Badshah, Syed Lal, et al.
Publicado: (2017)

Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
por: Demetriou, Victoria L, et al.
Publicado: (2010)

Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent
por: Kwon, Hyock Joo, et al.
Publicado: (2015)

1H-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease
por: Omar, Abdelsattar M., et al.
Publicado: (2020)

A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach
por: Riaz, Muhammad, et al.
Publicado: (2023)

Performance of NS3, NS5a AND NS5b Hepatitis C Virus (HCV) Antiviral Resistance Sequencing Assays
por: Nutt, Jamie, et al.
Publicado: (2017)

The Future of HCV Therapy: NS4B as an Antiviral Target
por: Dvory-Sobol, Hadas, et al.
Publicado: (2010)

Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase
por: Abidi, Syed Hani, et al.
Publicado: (2021)

Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR studies
por: Abuelizz, Hatem A., et al.
Publicado: (2020)

Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
por: Furuta, Atsushi, et al.
Publicado: (2015)

Dengue virus serotypic replacement of NS3 protease or helicase domain causes chimeric viral attenuation but can be recovered by a compensated mutation at helicase domain or NS2B, respectively
por: Teramoto, Tadahisa
Publicado: (2023)

A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
por: Isken, Olaf, et al.
Publicado: (2015)

Comparison of High-Resolution Computed Tomography and Real-Time Reverse Transcriptase Polymerase Chain Reaction in Diagnosis of COVID-19 Pneumonia in Intensive Care Unit Population
por: Murtaza, Hafiz G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jrnkaecdc0b6uvj6b0fggpdpo5